
Releases
Biosidus and Mubadala Bio Partner to Bring Biologics to the UAE
Argentina’s Biosidus has signed a licensing and supply agreement with Mubadala Bio, the life sciences arm of Mubadala Investment Company, to introduce a suite of complex biologic therapies into the United Arab Emirates. The deal was finalized at the BIO International Convention 2026 under the observation of Abu Dhabi health officials.



























